Inside the Melanocyte · Chapter 3 of 4
The short answer
Cysteamine is a small, naturally occurring molecule that your body already makes. Applied to the skin as a short-contact cream, it has been studied for its effect on several steps of melanin production at once. In randomized trials, topical cysteamine improved the look of melasma compared with placebo[1], and three meta-analyses found it performed comparably to hydroquinone in short-term studies[5][6][7].
- 01Multi-step: laboratory research describes cysteamine acting at several points of melanin chemistry, not just one[8].
- 02Evidence: three meta-analyses published in 2024 and 2026 found cysteamine better than placebo and not significantly different from hydroquinone over 4 to 16 weeks[5][6][7].
- 03Comfort: side effects reported in studies were mostly mild and temporary, such as redness, burning or itching[5].
- 04Format: apply, wait, rinse. Short contact is built for daily life.
In chapter one, we met the melanocyte. In chapter two, we met the neighbors that keep it switched on. Now the question everyone asks: what can actually help, and how do you choose? Let's start with the molecule Cyspera is built on.
What is cysteamine?
Cysteamine is an aminothiol, a small sulfur-containing molecule. Your body produces it naturally when it breaks down coenzyme A, and it acts as one of the antioxidants your cells already use. In skincare, it has been studied for one specific reason: its effect on how melanin is made[8].
Cysteamine is also notoriously unstable, which long kept it out of skincare. Scientis, the Swiss company behind Cyspera, was the first to stabilize cysteamine for use on the skin, and the Cyspera cysteamine complex is patented.
How does cysteamine work on pigmentation?
Most pigment ingredients were designed around one step: the enzyme tyrosinase. Research on cysteamine describes something broader. In laboratory studies, cysteamine was shown to[8]:
slow down tyrosinase, the enzyme behind the first two steps of melanin production;
neutralize dopaquinone, the branching point of melanin chemistry;
slow down peroxidase, an enzyme that helps assemble eumelanin;
bind iron and copper, metals the melanin process relies on;
raise levels of glutathione, one of the skin's own antioxidants, which steers chemistry away from the eumelanin pathway.
Why does that matter? Because, as we saw in chapter two, melanin production is the end of a long chain of signals. An ingredient studied at several points of that chain fits the way pigment actually works.
What do the clinical studies show?
Here is the evidence, with its size, its length and any link to Scientis. We think you should see all three.
| Study | Design | Who | Length | Main result | Scientis involvement |
|---|---|---|---|---|---|
| [1] Mansouri et al., Br J Dermatol 2015 | Randomized, double-blind, vs placebo | 50 people with melasma | 4 months | MASI score of 7.2 with cysteamine vs 11.6 with placebo at the end of the study. The cream was left on overnight, not used as a short-contact treatment. | Senior author is Scientis' Chief Scientific Officer |
| [2] Sachdev et al., J Drugs Dermatol 2024 | Randomized, double-blind, 3 arms: cysteamine-isobionic-amide complex, modified Kligman's formula, placebo | 80 people with melasma, skin types III to V | 16 weeks | Both active treatments reduced melasma severity (mMASI) with comparable efficacy at week 16, with a similar onset at week 4. Quality of life improved significantly more with the cysteamine complex (P<0.001). | Sponsored by Scientis; authors are Scientis consultants or investigators |
| [3] Liu et al., Dermatologica Sinica 2023 | Randomized, double-blind, vs base cream (vehicle) | 40 people with post-inflammatory hyperpigmentation, Taiwan | 16 weeks | Significant improvement with the cysteamine complex vs the base cream from week 8. | One co-author is also a Sachdev 2024 author |
| [4] Karrabi et al., Arch Dermatol Res 2021 | Randomized, single-blind: cysteamine 5% cream at night vs tranexamic acid micro-injections (mesotherapy) | 54 people with melasma | 4 months | Both groups improved (mMASI), with no significant difference between them. Fewer side effects in the cysteamine group. | None declared |
| [5] Wu et al., J Clin Med 2024 | Meta-analysis of randomized trials | 8 studies, 415 people | 4 to 16 weeks | Cysteamine better than placebo. No significant difference between cysteamine and hydroquinone-based treatments. | None identified |
| [6] Mawu and Christopher, Arch Dermatol Res 2024 | Meta-analysis of 7 randomized trials | People with melasma, cysteamine 5% cream | Short term | Cysteamine better than placebo on MASI. No significant difference between cysteamine and hydroquinone 4%. | None identified |
| [7] Milanesi et al., Arch Dermatol Res 2026 | Meta-analysis of 5 randomized trials | 193 people | Short term | No significant difference between cysteamine and hydroquinone in mMASI response or in side effects. | None identified |
The honest part
Most trials are small, many were run in Iran and Asia, and none followed people beyond 16 weeks. One review suggested results may be lower in people who have had melasma for longer, although that finding is uncertain. We would rather tell you than have you find out.
Cysteamine vs hydroquinone vs tranexamic acid
| Cysteamine | Hydroquinone | Tranexamic acid | |
|---|---|---|---|
| What it is | A naturally occurring molecule (aminothiol) | A long-standing prescription pigment treatment | A medicine originally used to control bleeding |
| How it is used | Short-contact cream, rinsed off, at home | Leave-on cream, usually in limited courses under medical supervision | Prescription tablets, or micro-injections into the skin (mesotherapy) by a physician; also found in skincare |
| Compared with cysteamine | Reference | No significant difference over 4 to 16 weeks in three meta-analyses[5][6][7] | One randomized trial (54 people) compared cysteamine cream with tranexamic acid micro-injections: both improved, with no significant difference, and fewer side effects with cysteamine[4] |
| Side effects reported | Mostly mild and temporary redness, burning or itching[5] | Irritation; with prolonged use, ochronosis (bluish-black darkening), which can be permanent[10] | Depends on the form; your doctor will review |
| Access in the US | Cosmetic cream, no prescription | Prescription only: no over-the-counter product is legally marketed since 2020[9] | Oral form by prescription |
Bottom line
Hydroquinone and tranexamic acid are established medical options that belong in a dermatologist's hands. Cysteamine has been compared with both: no significant difference versus hydroquinone in short-term meta-analyses[5][6][7], and similar improvement versus tranexamic acid micro-injections in one trial[4], in a cosmetic format you use at home. The right choice depends on your skin, your history and your doctor's advice.
Why do you rinse cysteamine off?
Because short contact is the point. Cyspera's cysteamine creams are designed to be applied, left on for 5 to 15 minutes, then rinsed. Starting at 5 minutes and building up helps your skin get used to it. The 16-week Sachdev study tested the cysteamine complex used this way[2].
- Chapter 1Meet the melanocyteRead it
- Chapter 2What wakes it upRead it
- Chapter 3How cysteamine worksYou are here
- Chapter 4The pigment care protocolComing next
How Cyspera fits
| Product | For and key ingredients | How to use |
|---|---|---|
| CYSPERA INTENSIVE | Stubborn-looking dark spots and uneven tone. Cysteamine 7% with Isobionic-Amide. | Once a day on unwashed skin: start with 5 minutes, build up to 15, then rinse. |
| CYSPERA SENSITIVE | Sensitive or reactive skin and delicate areas. Cysteamine, in a formula designed for comfort. | Once a day on unwashed skin for 5 to 15 minutes (5 minutes on delicate areas), then rinse. |
| CYSPERA AGELESS | The daily second step for comfort and radiance. Isobionic-Amide with retinol and vitamin C and E derivatives. | A thin layer once a day, after rinsing, or on its own. |
How long, and how often? The correction and maintenance phases are covered step by step in chapter 4, The Pigment Care Protocol.
Together, they are designed to visibly reduce the appearance of dark spots and help even out the look of your skin tone. Find your routine.
Frequently asked questions
How long does cysteamine take to work?
In the 16-week Sachdev study, the cysteamine complex already showed an effect on melasma severity at week 4, similar to modified Kligman's formula[2]. DermNet notes visible improvement from about 6 weeks, with the best results around 8 to 12 weeks[8]. Cyspera's correction phase runs for 16 weeks.
Is cysteamine better than hydroquinone?
Not better: comparable. Three meta-analyses found no significant difference between topical cysteamine and hydroquinone over 4 to 16 weeks. The differences are in format and access: cysteamine is a short-contact cosmetic, hydroquinone is prescription-only in the US.
Is cysteamine safe for dark skin?
The main studies of Cyspera's cysteamine complex enrolled people with skin types III to V, and reported side effects were mostly mild and temporary. As with any active, start slowly, and ask a dermatologist if you have concerns.
Why does cysteamine sting at first?
Some people feel mild warmth, redness or itching at first. In the studies pooled in one meta-analysis, these effects were mostly mild and temporary[5]. Starting with 5 minutes of contact and building up to 15 helps your skin get used to it.
Who funds the research on Cyspera?
Some of it, Scientis, the company behind Cyspera. The 2024 Sachdev trial was sponsored by Scientis and its authors have worked with the company. Independent trials and meta-analyses also exist. We list the funding of every study we cite.
References
- Mansouri P, et al. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. British Journal of Dermatology. 2015;173(1):209-217.
- Sachdev M, Grimes PE, Callender V, Hartman CL, Taylor SC, Elbuluk N, Badawi A, Funasaka Y, Lim J, Ng CY, Desai SR. Cysteamine isobionic-amide complex versus Kligman's formula for the treatment of melasma: equal efficacy and rapid onset of action. Journal of Drugs in Dermatology. 2024;23(2):9-16. doi:10.36849/JDD.7428.
- Liu RT-L, Tsai T-F, Lai Y-J, Ng CY. Efficacy and safety of cysteamine-isobionicamide complex in postinflammatory hyperpigmentation: a 16-week, randomized, double-blinded, vehicle-controlled trial. Dermatologica Sinica. 2023;41(4):222-230.
- Karrabi M, Mansournia MA, Sharestanaki E, et al. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study. Archives of Dermatological Research. 2021;313:539-547.
- Wu B-Q, Wang Y-J, Chang C-C, Juang T-Y, Huang Y-H, Hsu Y-C. Clinical efficacy of cysteamine application for melasma: a meta-analysis. Journal of Clinical Medicine. 2024;13(23):7483.
- Mawu, Christopher. Efficacy and safety of cysteamine 5% cream for the management of melasma: a systematic review and meta-analysis of randomized controlled trials. Archives of Dermatological Research. 2024.
- Milanesi et al. Comparative efficacy and safety of cysteamine and hydroquinone in the treatment of facial melasma: a systematic review and meta-analysis of randomized clinical trials. Archives of Dermatological Research. 2026.
- DermNet. Cysteamine cream. Updated 2026.
- US Food and Drug Administration. FDA works to protect consumers from potentially harmful OTC skin lightening products. 2022.
- US Food and Drug Administration. FDA warns consumers about skin products containing mercury and/or hydroquinone.
Disclosure: the Cyspera Science Team and the reviewer work for Scientis SA, the company behind Cyspera. Dr Behrooz Kasraee, senior author of the 2015 Mansouri trial, is Chief Scientific Officer and a shareholder of Scientis SA. This article is educational and is not medical advice. CYSPERA products are cosmetics and are not intended to diagnose, treat, cure or prevent any disease.
